Ginkgo Bioworks Holdings, Inc. DNA
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 285.36M | 302.16M | 373.46M | 422.62M | 461.86M |
| Total Receivables | 11.49M | 13.01M | 20.27M | 24.26M | 22.36M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 12.13M | 14.44M | 9.35M | 17.93M | 13.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.86M | 2.92M | 6.88M | 7.03M | 8.80M |
| Total Current Assets | 310.84M | 332.54M | 409.96M | 471.84M | 506.08M |
|
|
|||||
| Total Current Assets | 310.84M | 332.54M | 409.96M | 471.84M | 506.08M |
| Net Property, Plant & Equipment | 493.84M | 504.85M | 516.82M | 528.70M | 544.79M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 39.73M | 44.39M | 48.86M | 56.92M | 61.52M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 85.48M | 85.89M | 42.73M | 47.17M | 46.59M |
| Total Assets | 944.45M | 990.05M | 1.03B | 1.12B | 1.19B |
|
|
|||||
| Total Accounts Payable | 7.18M | 9.58M | 16.31M | 10.57M | 10.70M |
| Total Accrued Expenses | 46.84M | 44.51M | 42.94M | 15.57M | 52.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 22.81M | -- |
| Total Finance Division Other Current Liabilities | 11.83M | 18.65M | 20.35M | 47.03M | 52.07M |
| Total Other Current Liabilities | 11.83M | 18.65M | 20.35M | 47.03M | 52.07M |
| Total Current Liabilities | 65.85M | 72.74M | 79.60M | 95.97M | 115.28M |
|
|
|||||
| Total Current Liabilities | 65.85M | 72.74M | 79.60M | 95.97M | 115.28M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 397.20M | 404.11M | 410.70M | 417.08M | 422.87M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 88.77M | 92.91M | 99.63M | 98.06M | 91.23M |
| Total Liabilities | 551.82M | 569.76M | 589.92M | 611.11M | 629.38M |
|
|
|||||
| Common Stock & APIC | 6.71B | 6.70B | 6.67B | 6.66B | 6.63B |
| Retained Earnings | -6.32B | -6.28B | -6.23B | -6.15B | -6.07B |
| Treasury Stock & Other | 115.00K | 950.00K | 1.19M | 1.85M | 2.00M |
| Total Common Equity | 392.64M | 420.28M | 443.15M | 508.59M | 559.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 392.64M | 420.28M | 443.15M | 508.59M | 559.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 392.64M | 420.28M | 443.15M | 508.59M | 559.78M |
|
|
|||||